p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression.

doi:10.1093/jnci/95.10.723

Article

p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression.

Journal of the National Cancer Institute - 21 May 2003

Sviderskaya Elena V, Gray-Schopfer Vanessa C, Hill Simon P, Smit Nico P, Evans-Whipp Tracy J, Bond Jane, Hill Lucy, Bataille Veronique, Peters Gordon, Kipling David, Wynford-Thomas David, Bennett Dorothy C

Abstract excerpt

BACKGROUND: The melanoma susceptibility locus cyclin-dependent kinase inhibitor 2A encodes two unrelated cell growth inhibitors, p16 and alternative reading frame (ARF). In fibroblasts, both proteins are implicated in cellular senescence, a key barrier to tumor development. The p16 coding sequenc...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression.

Abstract excerpt

Topics

Related research